Synlait Milk (SML) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
22 Mar, 2026Executive summary
Reported a net loss after tax of NZD 80.6 million for the half year, driven by manufacturing challenges, inventory shortfalls, and a global downturn in whole milk powder pricing, with North Island operations classified as discontinued and sale expected to complete 1 April 2026.
EBITDA loss was NZD 34.7 million, with net debt increasing to NZD 472.1 million, up 88% year-over-year.
A recovery roadmap is underway, focusing on stabilizing operations, simplifying the business, and scaling growth, with new executive leadership in Canterbury.
Directors consider the financial statements prepared on a going concern basis, but material uncertainty remains regarding access to capital and refinancing.
Sale of North Island assets to Abbott for NZD 307 million is on track, expected to reduce debt and remove a loss-making asset.
Financial highlights
Total group revenue was NZD 949 million, with underlying EBITDA at NZD 4.1 million and underlying net loss after tax at NZD 27.3 million.
Gross profit dropped sharply, turning negative at NZD (1.4) million, down from NZD 94.5 million in the prior year.
Operating cash flow was a net outflow of NZD 183.4 million, mainly due to working capital build and weak operating performance.
Net debt increased to NZD 472.1 million, with loans and borrowings at NZD 504.4 million as of 31 January 2026.
Milk price forecast for 2025/26 season raised to NZD 9.70, with total forecast including premiums at NZD 10.10.
Outlook and guidance
No FY26 financial guidance provided; leadership is focused on executing the recovery plan and expects improved performance post-asset sale.
Management targets operational stability and margin recovery over the next 12–24 months, with focus on South Island operations and stable production lines.
Completion of the North Island asset sale is expected to materially reduce senior debt and strengthen liquidity.
Latest events from Synlait Milk
- Asset sale and board changes passed with over 99% approval, targeting debt reduction and growth.SML
AGM 20253 Feb 2026 - Large FY24 loss, balance sheet reset, and recovery hinges on trading and milk supply retention.SML
H2 202420 Jan 2026 - Major loss, balance sheet reset, and FY25 growth priorities with strong shareholder backing.SML
AGM 202412 Jan 2026 - Profitability restored, revenue and EBITDA up, net debt down, but refinancing risk remains.SML
H1 202526 Dec 2025 - Record revenue and North Island asset sale drive debt reduction and strategic reset.SML
H2 202529 Sep 2025